Characteristics | No. of tumors examined | WT | KRAS mutation | (%) | p |
Total | 103 |
| 11 | (11) |
|
Age (mean) | 67.0 |
| 68.3 |
|
|
Gender |
|
|
|
|
|
Male | 74 | 64 | 10 | (14) |
|
Female | 29 | 28 | 1 | (3) | NS |
Smoking status |
|
|
|
|
|
Never | 26 | 25 | 1 | (4) |
|
Ex-smoker | 26 | 23 | 3 | (12) |
|
Current | 51 | 44 | 7 | (14) | NS |
Smoking index |
|
|
|
|
|
<799 | 46 | 42 | 4 | (9) |
|
>800 | 57 | 50 | 7 | (12) | NS |
Histological differentiation |
|
|
|
|
|
Adenocarcinoma | 69 | 63 | 6 | (9) | NS |
Squamous cell ca. | 26 | 24 | 2 | (8) |
|
Adenosquamous ca. | 2 | 1 | 1 | (50) |
|
LCNEC | 6 | 4 | 2 | (33) |
|
Patholoical stage |
|
|
|
|
|
I | 51 | 47 | 4 | (8) | NS |
II | 27 | 22 | 5 | (19) |
|
III | 22 | 20 | 2 | (8) |
|
IV | 3 | 3 | 0 | (0) |
|
CADM1 genes |
|
|
|
|
|
Methylated | 45 | 41 | 4 | (9) | NS |
Unmethylated | 58 | 51 | 7 | (12) |
|
EGFR |
|
|
|
|
|
Mutated | 11 | 11 | 0 | (0) | p < 0.05 |
Not mutated | 92 | 65 | 27 | (32) |
|
CADM1 gene |
|
|
|
|
|
Methylated | 45 | 41 | 4 | (9) | NS |
Unmethylated | 58 | 51 | 7 | (12) |
|
4.1B gene |
|
|
|
|
|
Methylated | 59 | 51 | 8 | (14) | NS |
Unmethylated | 44 | 41 | 3 | (7) |
|
CADM1 or 4.1B gene |
|
|
|
|
|
Both or either methylated | 71 | 62 | 9 | (13) | NS |
Both unmethylated | 32 | 30 | 2 | (6) |
|